Last reviewed · How we verify
NCT04097964
Examining the Effectiveness of the FaCES Adolescent SBIRT Intervention
NA trial testing brief intervention in Adolescent Health Services in 1,226 participants. Completed in 30 June 2021.
30 June 2021
Quick facts
| Lead sponsor | Friends Research Institute, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 1,226 |
| Start date | 15 March 2018 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- brief intervention
- treatment as usual
Conditions studied
- Adolescent Health Services — all drugs for Adolescent Health Services →
- Adolescent Behavior — all drugs for Adolescent Behavior →
Sponsor
Friends Research Institute, Inc.
Who can join
Adults 12 to 17, any sex, with Adolescent Health Services or Adolescent Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will utilize a stepped wedge cluster randomized design to examine the effectiveness of the full FaCES (Facilitating Change for Excellence in SBIRT) adolescent SBIRT change package. Primary care providers will be randomized as to when they receive training and begin delivery of FaCES with their 12 to 17 year old patients, which includes targeted feedback based on the patient's endorsed substance use level on the S2BI screening instrument.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04097964
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of brief intervention
Trials testing the same drug.
- NCT06403332 — Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal A · NA · recruiting
Other Friends Research Institute, Inc. trials
Trials by the same sponsor.
- NCT07262190 — NavSTAR Implementation Effectiveness Trial Across a Health System · NA · recruiting
- NCT06306443 — Buprenorphine for Individuals in Jail · Phase 3 · recruiting
- NCT06573476 — Addressing Racial Disparities in Opioid Overdose Using Peer Recovery Coach Training and mHealth Platform · NA · recruiting
- NCT07524738 — Telemedicine XR-B for Individuals in Jail · Phase 3 · active not recruiting
- NCT06569667 — Using AI and Peer Coaching to Address Racial Disparities Among People Who Use Opioids · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04097964 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Friends Research Institute, Inc.
- Last refreshed: 22 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04097964.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing